title: Immunologic markers of systemic scleroderma in children.
abstract: This study was performed on seven children with systemic scleroderma, three with the diffuse and four with the limited type. All three patients with diffuse scleroderma had high titers of clumpy pattern antinucleolar antibody on HEp-2 cells. The course of the disease was severe, and two children died. Four children with limited scleroderma had mild disease, and Scl-70 antibody, an immunologic marker that in adults is associated mostly with diffuse scleroderma. In one child Scl-70 antibody and anticentromere antibody coexisted, although previously the two were believed to be mutually exclusive. This study shows that limited scleroderma of childhood with slight cutaneous involvement may be associated with the Scl-70 marker. The findings in 10 adults in whom Raynaud's phenomenon developed in childhood and indurations appeared some years later, point to the significance of careful observation of these children, with repeated testing for immunologic markers of SSc. An important new finding is the association of different types of systemic sclerodermas with specific immunologic markers.
authors.affiliation: Department of Dermatology, Warsaw School of Medicine, Poland.
authors.forename: M
authors.initials: M
authors.lastname: Błaszczyk
authors.forename: S
authors.initials: S
authors.lastname: Jabłońska
authors.forename: W
authors.initials: W
authors.lastname: Szymańska-Jagiełło
authors.forename: M
authors.initials: M
authors.lastname: Jarzabek-Chorzelska
authors.forename: T
authors.initials: T
authors.lastname: Chorzelski
mesh_terms: D000293:Adolescent; D000974:Antibodies, Antinuclear / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D015151:Immunoblotting; D005779:Immunodiffusion; D008297:Male; D011928:Raynaud Disease / Q000150:complications / Q000276:immunology; D012595:Scleroderma, Systemic / Q000150:complications / Q000276:immunology*
chemical_list: D000974:Antibodies, Antinuclear